DTYMK and ovarian serous cystadenocarcinoma: Gene amplification of DTYMK was more common in cancers such as ovarian serous cystadenocarcinoma (OV), uterine carcinosarcoma (UCS), pancreatic adenocarcinoma (PAAD), LUAD, thymoma (THYM), and LIHC (Figure 1C).